Back
X4 Pharmaceuticals 10K Form
Sell
34
XFOR
X4 Pharmaceuticals
Last Price:
0.37
Seasonality Move:
2.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XFOR News And Ratings
See the #1 stock for the next 7 days that we like better than XFOR
XFOR Financial Statistics
Sales & Book Value
| Annual Sales: | $3M |
|---|---|
| Cash Flow: | $-34.12M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.35 |
| Price / Book: | 1.05 |
Profitability
| EPS (TTM): | -0.08000 |
|---|---|
| Net Income (TTM): | $-16.76M |
| Gross Margin: | -- |
| Return on Equity: | -30.6% |
| Return on Assets: | -10.2% |
X4 Pharmaceuticals Earnings Forecast
Key X4 Pharmaceuticals Financial Ratios
- The Interest Expense is -5.71% of Operating Income.
- Per Share Earnings over the last 9 years have been positive in 5 years.
X4 Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XFOR |
| CUSIP: | 98420X |
| Website: | x4pharma.com |
Debt
| Debt-to-Equity Ratio: | 1.26 |
|---|---|
| Current Ratio: | 4.89 |
| Quick Ratio: | 4.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XFOR Technical Analysis vs Fundamental Analysis
Sell
34
X4 Pharmaceuticals (XFOR)
is a Sell
Is X4 Pharmaceuticals a Buy or a Sell?
-
X4 Pharmaceuticals stock is rated a Sell
The current X4 Pharmaceuticals [XFOR] share price is $0.37. The Score for XFOR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.